WPG Advisers’s CG Oncology CGON Stock Holding History

WPG Advisers’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$71	Hold	1	–	–	﹤0.01%	1580
2026 Q2	$71	Hold	1	–	–	﹤0.01%	1535
2026 Q1	$68	Hold	1	–	–	﹤0.01%	1463
2025 Q4	$42	Buy	+1	New	+$41	﹤0.01%	1475

Other funds holding CGON

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

AGF Management Toronto, Ontario, Canada $24.5B AUM 50.2% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return

WPG Advisers's CGON Position: Q3 2026 in Review

WPG Advisers held its CG Oncology (CGON) position steady in Q3 2026 at 1 share worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

WPG Advisers first reported a position in CGON in Q4 2025 and has held it in 4 quarters since. 55 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

WPG Advisers held 1 share of CG Oncology worth $71 as of Q3 2026.
WPG Advisers left its CG Oncology share count unchanged in Q3 2026.
CG Oncology made up ﹤0.01% of WPG Advisers's portfolio in Q3 2026, its #1580 holding.
WPG Advisers first reported a position in CG Oncology in Q4 2025 and has held it in 4 quarters since.
55 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.